Previous Article | Next Article 
Journal of Clinical Microbiology, April 1998, p. 1164-1164, Vol. 36, No. 4
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
LETTERS TO THE EDITOR
Effect of Nonionic Detergents on Amplification of Human
Papillomavirus DNA with Consensus Primers MY09 and MY11
 |
LETTER |
Crude cell lysates, obtained by protein digestion and membrane
lysis with nonionic detergents such as Nonidet P-40 (NP-40), Tween 20, or Laureth 12, followed by heat denaturation, are suitable for PCR analysis (1). The L1 consensus PCR assay with the
MY09-MY11 primer pair is widely utilized for detection of human
papillomavirus (HPV) DNA (2, 3, 7, 10). However, the use of
NP-40 is not proposed in PCR protocols using MY09-MY11 (1).
Several investigators consider that NP-40 could impair the
amplification process with MY09-MY11 (5a), although some
have used it with success (4-6, 9). The effect of
NP-40 on amplification with MY09-MY11 has not been reported yet.
Since NP-40 is not inhibitory for Taq polymerase at
concentrations below 0.1% (8) and since it is commonly used
in sample-processing protocols, we have evaluated the effect of NP-40
on the detection of HPV DNA with the MY09-MY11 primer
pair.

View larger version (102K):
[in this window]
[in a new window]
|
FIG. 1.
Amplification of eight copies of HPV-16 accomplished in
the presence of TE buffer (lanes b, c, and d), 0.04% (final
concentration [vol/vol]) NP-40 and 0.04% Tween (lanes e and f),
0.08% Tween 20 (lanes g and h), and 0.08% NP-40 (lanes i and j). The
negative control is in lane a. Amplification was done with AmpliTaq
Gold DNA polymerase in a model 9600 DNA thermal cycler. A 450-bp band
is visible in positive reactions.
|
|
Ten-microliter volumes of the detergent preparations described below
were added to 90-µl volumes of a PCR master mix containing the usual
components (2, 7) plus eight copies of HPV-16 (kindly
provided by H. zur Hausen), 5 U of AmpliTaq Gold DNA polymerase (Perkin-Elmer, Montréal, Canada), and the L1 consensus HPV
primers MY09 and MY11. Detergent solutions included (i) 10 µl of
Tris-HCl (pH 7.4) with 0.01 mM EDTA (TE) (no-detergent control
solution), (ii) 10 µl of a solution of 0.4% Tween 20 and 0.4%
NP-40, (iii) 10 µl of a solution of 0.8% Tween 20, (iv) 10 µl of a
solution of 0.8% NP-40, and (v) 10 µl of a solution of 0.8% Laureth
12 (kindly provided by P. Gravitt, Roche Molecular Systems). Final concentrations of nonionic detergents in the amplification mixtures reached 0.08%. This corresponds to the final concentration of detergents in the PCR mixture, since in our usual PCR protocols specimens are treated with 0.8% detergents and represent 10% of the
final amplification reaction volume. Amplification was performed in a
model 9600 thermal cycler with the following cycling conditions: activation of AmpliTaq Gold at 95°C for 9 min; 40 cycles of DNA amplification at 95°C for 20 s, 55°C for 30 s, and 72°C
for 30 s; and a final elongation step at 72°C for 5 min.
Amplified material was subjected to electrophoresis on a 2% agarose
gel stained with ethidium bromide and visualized on a UV
transilluminator.
As shown in Fig. 1, detection of eight copies of HPV-16 was impaired by
the presence of NP-40 with or without Tween 20. Results similar to
those with Tween 20 were obtained with Laureth 12 (data not shown).
Three independent experiments generated similar results. The detection
of 80 copies of HPV-16 DNA was not affected by the presence of
NP-40 (data not shown). Our results do not support the use of NP-40 for
cell lysis of samples analyzed with the MY09-MY11 primer pair for
detection of low-viral-load infections. Tween 20 or Laureth 12 did not
alter the efficiency of PCR amplification for HPV detection at
concentrations of at most 0.08%.
 |
REFERENCES |
| 1.
|
Bauer, H. M.,
C. E. Greer, and M. M. Manos.
1992.
Determination of genital human papillomavirus infection by consensus polymerase chain reaction amplification, p. 131-152.
In
C. S. Herrington, and J. O. D. McGee (ed.), Diagnostic molecular pathology, a practical approach. IRL Press, Oxford, United Kingdom.
|
| 2.
|
Bauer, H. M.,
Y. Ting,
C. E. Greer,
J. C. Chambers,
C. J. Tashiro,
J. Chimera,
A. Reingold, and M. M. Manos.
1991.
Genital human papillomavirus infection in female university students as determined by a PCR-based method.
JAMA
265:472-477[Abstract/Free Full Text].
|
| 3.
|
Bosch, F. X.,
M. M. Manos,
N. Muñoz,
M. Sherman,
A. M. Jansen,
J. Peto,
M. H. Schiffman,
V. Moreno,
R. Kurman,
K. V. Shah, and IBSCC Study Group.
1995.
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective.
J. Natl. Cancer Inst.
87:796-802[Abstract/Free Full Text].
|
| 4.
|
Coutlée, F.,
D. Provencher, and H. Voyer.
1995.
Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay.
J. Clin. Microbiol.
33:1973-1978[Abstract].
|
| 5.
|
Coutlée, F.,
A. M. Trottier,
G. Ghattas,
R. Leduc,
E. Toma,
G. Sanche,
I. Rodrigues,
B. Turmel,
G. Allaire, and P. Ghadirian.
1997.
Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus.
Sex. Transm. Dis.
24:23-31[Medline].
|
| 5a.
| Gravitt, P. Personal communication.
|
| 6.
|
Guerrero, E.,
R. W. Daniel,
F. X. Bosch,
X. Castellsagué,
N. Munoz,
M. Gili,
P. Viladu,
C. Navarro,
M. L. Zubiri,
N. Ascunce,
L. C. Gonzales,
L. Tafur,
I. Izaraugaza, and K. V. Shah.
1992.
Comparison of Virapap, Southern blot hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer.
J. Clin. Microbiol.
30:2951-2959[Abstract/Free Full Text].
|
| 7.
|
Hildesheim, A.,
M. H. Schiffman,
P. E. Gravitt,
A. G. Glass,
C. E. Greer,
T. Zhang,
D. R. Scott,
B. B. Rush,
P. Lawler,
M. E. Sherman,
R. J. Kurman, and M. M. Manos.
1994.
Persistence of type-specific human papillomavirus infection among cytologically normal women.
J. Infect. Dis.
169:235-240[Medline].
|
| 8.
|
Kawasaki, E. S.
1990.
Sample preparation from blood, cells, and other fluids, p. 146-152.
In
M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, New York, N.Y.
|
| 9.
|
Manos, M. M.,
Y. Ting,
D. K. Wright,
A. J. Lewis,
T. Broker, and S. M. Wolinski.
1989.
Use of the polymerase chain reaction amplification for the detection of genital human papillomaviruses.
Cancer Cells
7:209-215.
|
| 10.
|
Schiffman, M. H.,
H. M. Bauer,
R. N. Hoover,
A. G. Glass,
D. M. Cadell,
B. B. Rush,
D. R. Scott,
M. E. Sherman,
R. J. Kurman,
S. Wacholder,
C. K. Stanton, and M. M. Manos.
1993.
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
J. Natl. Cancer Inst.
85:958-963[Abstract/Free Full Text].
|
| | | | |
François Coutlée
Hélène Voyer
Departement de Microbiologie et Maladies Infectieuses Centre Hospitalier de l'Université de Montréal Pavillon Notre-Dame Montréal, Québec, Canada
|
Journal of Clinical Microbiology, April 1998, p. 1164-1164, Vol. 36, No. 4
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.